Clinical Trial

Gait in Young Children With NF1

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to develop office-based tools to quantify gait in young children with NF1 that reflect overall gross motor impairment and predict future gross motor difficulties.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-27.
Trial Details
NCT Number NCT07564622
Lead Sponsor NYU Langone Health
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Conditions Neurofibromatosis Type 1
Enrollment 56 participants
Start Date 2026-08
Primary Completion 2030-01-31 (estimated)
Study Completion 2031-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-08